Representatives of the pharma industry and drug distributors have told an influential committee of MPs that patients should consider stockpiling their own drugs if a “no deal” Brexit scenar
AstraZeneca will keep manufacturing investments in Britain on hold if the UK’s negotiations with Brussels fail to provide clarity on future trading relations, according to press reports.
Despite the government insisting that Brexit will have no negative fallout, the UK's drugs regulator is consulting on whether it can become a standalone body with no links to European count
